共 9 条
- [3] Pre-implant Phosphodiesterase-5 Inhibitor Use is Associated With Higher Rates of Severe Early Right Heart Failure After LVAD Implantation: An INTERMACS Analysis JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S195 - S195
- [4] Post-Implant Phosphodiesterase-5 Inhibitor Use is Associated with Increased Rates of Late Right Heart Failure after LVAD: An INTERMACS Analysis JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S229 - S230
- [8] Response by Soliman et al to Letter Regarding Article, "Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients With Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score" CIRCULATION, 2018, 138 (06) : 658 - 659
- [9] Response by Schrage et al to Letter Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry" CIRCULATION, 2020, 141 (11) : E648 - E649